Status:

COMPLETED

Efficacy and Safety of Adding Atracurium to Percaruncular Block for High Myopes Undergoing Cataract Surgery

Lead Sponsor:

Kasr El Aini Hospital

Conditions:

Quality of Ocular Akinesia (Onset and Duration)

Eligibility:

All Genders

18-75 years

Phase:

PHASE4

Brief Summary

There are several local anesthetic techniques available for cataract surgery and the choice depends on patient, surgical and operator factors. The eyes of patients with axial myopia (the eye globe is ...

Detailed Description

In the current study, it is hypothesized that adding low dose atracurium to lidocaine, bupivacaine and hyaluronidase mixture would provide an early onset of akinesia and favorable surgical condition i...

Eligibility Criteria

Inclusion

  • American Society of Anesthesiologists (ASA) physical status I-III
  • high myopia (axial length 26mm or more)

Exclusion

  • Pregnant patients.
  • ASA physical status \>III.
  • Axial length less than 26 mm.
  • Contraindication of regional anesthesia:
  • Absolute contraindications: Patient refusal to participate in the study, Local anesthetic allergy and Infection/marked orbital inflammation or, Relative contraindications: unable to lie flat for a sufficient length of time, Confusion or psychiatric illness, communication difficulties, bleeding diathesis or taking anticoagulants, Previous scleral buckling or space-occupying lesions within the orbit

Key Trial Info

Start Date :

May 1 2015

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

May 1 2016

Estimated Enrollment :

91 Patients enrolled

Trial Details

Trial ID

NCT03243500

Start Date

May 1 2015

End Date

May 1 2016

Last Update

August 9 2017

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Kasr Alaini Hospital

Cairo, Egypt, 11562